Salveen Richter

Stock Analyst at Goldman Sachs

(0)
# 4791
Out of 5,386 analysts
221
Total ratings
Success rate
Average return
54 Stocks
Name Action PT Current % Upside Ratings Updated
SRPT Sarepta Therapeutics
Downgrades: Neutral
29
17.1 69.59% 5 Jun 17, 2025
ELVN Enliven Therapeutics
Initiates Coverage On: Buy
37
20.68 78.92% 1 Jun 16, 2025
FDMT 4D Molecular Therape...
Maintains: Buy
51 44
3.83 1048.83% 4 May 9, 2025
CRSP CRISPR Therapeutics
Maintains: Neutral
53 47
47.45 -0.95% 4 May 8, 2025
RCUS Arcus Biosciences
Maintains: Neutral
15 13
7.95 63.52% 3 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
124 104
55.12 88.68% 1 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
37 41
20.62 98.84% 2 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
12 9
5.94 51.52% 2 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 10
11.78 -15.11% 10 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
917 804
520.94 54.34% 5 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
219 197
125.95 56.41% 4 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
36 32
17.43 83.59% 8 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
3.29 447.11% 3 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
85 96
110.71 -13.29% 4 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
99 51
27.17 87.71% 10 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 40
14.09 183.89% 5 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
20 12
9.56 25.52% 8 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 20
13.83 44.61% 7 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
63 70
68.36 2.4% 6 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
198 370
322.64 14.68% 5 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
67 76
36.51 108.16% 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
33 37
39.83 -7.11% 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
19 11
9.15 20.22% 9 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
33 53
33.52 58.11% 8 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
313 350
277.28 26.23% 4 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
442 559
441.18 26.71% 4 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 4 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
5 5
13.14 -61.95% 5 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 31
1.18 2527.12% 7 Mar 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
257 225
305.08 -26.25% 1 Feb 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
22
2.42 809.09% 1 Nov 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 30
4.3 597.67% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 14
0.88 1490.91% 3 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 9
5.01 79.64% 6 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
16 3
2.4 25% 4 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
15 12
22.09 -45.68% 8 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 6
2.83 112.01% 3 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
39 43
57.02 -24.59% 1 Oct 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
40 60
n/a n/a 6 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
216 188
n/a n/a 3 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
125 100
7.81 1180.41% 1 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 4
n/a n/a 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
3 2
1.44 38.89% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
39 34
n/a n/a 3 Mar 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 5
n/a n/a 2 Jan 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
17 10
n/a n/a 5 Aug 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
28 30
n/a n/a 3 Mar 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
57 50
94.92 -47.32% 3 Mar 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
45
16.06 180.2% 1 Mar 17, 2020